- Report
- January 2024
- 175 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- January 2024
- 175 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- January 2024
- 175 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- January 2024
- 200 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- January 2024
- 200 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- November 2023
- 175 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- November 2023
- 175 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- January 2024
- 200 Pages
Global
From €2381EUR$2,490USD£2,040GBP
- Report
- March 2024
- 194 Pages
Global
From €4733EUR$4,950USD£4,056GBP
- Report
- March 2024
- 194 Pages
Global
From €4733EUR$4,950USD£4,056GBP
- Report
- March 2024
- 269 Pages
Global
From €5212EUR$5,450USD£4,466GBP
- Report
- October 2023
- 142 Pages
Global
From €2390EUR$2,499USD£2,048GBP
- Report
- January 2024
- 200 Pages
Global
From €3968EUR$4,150USD£3,401GBP
- Report
- January 2024
- 193 Pages
Global
From €3474EUR$3,633USD£2,977GBP
€4963EUR$5,190USD£4,253GBP
- Report
- December 2023
- 171 Pages
Global
From €3474EUR$3,633USD£2,977GBP
€4963EUR$5,190USD£4,253GBP
- Clinical Trials
- February 2024
- 80 Pages
Global
From €1195EUR$1,250USD£1,024GBP
- Report
- November 2023
- 30 Pages
Global
From €2630EUR$2,750USD£2,253GBP
- Report
- November 2023
- 30 Pages
Global
From €2630EUR$2,750USD£2,253GBP
- Report
- November 2023
- 30 Pages
Global
From €2630EUR$2,750USD£2,253GBP
- Report
- November 2023
- 30 Pages
Global
From €2630EUR$2,750USD£2,253GBP
The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs.
Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more